🔎 Trials Near Me

Dachaigh › Brùthadh Fola Àrd ann an Arteries an Sgamhain › California

Sgrùdaidhean clionaigeach Brùthadh Fola Àrd ann an Arteries an Sgamhain ann an California

Tha 12 sgrùdaidhean airson Brùthadh Fola Àrd ann an Arteries an Sgamhain a’ lorg phàirtichean aig làraichean ann an California.

Bailtean ann an California

Teacsa sgrùdaidh oifigeil (Beurla)

A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)

  • UC Davis - Medial Center ( Site 1064), Sacramento
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT07218029

A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)

  • USA012, Los Angeles
  • USA008, Santa Barbara
  • USA005, Torrance
A’ fastadhÌre 3
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 16 Sult 2026 · NCT07481981

An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)

  • Cedars Sinai, Beverly Hills
  • Jeffrey S. Sager, MD Medical Corporation, Santa Barbara
  • Lundquist at Harbor UCLA, Torrance
A’ fastadhÌre 3
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 2 Sult 2026 · NCT07365332

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

  • Lucile Packard Children's Hospital, Palo Alto
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 0 gu 20 · Gach gnè · Air ùrachadh 21 Lùna 2026 · NCT04278404

A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)

  • University of California Davis Health, Rancho Cordova
A’ fastadhÌre 2
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 10 Lùna 2026 · NCT07175038

Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)

  • Valley Advanced Lung Diseases Institute, Fresno
  • Department of Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles
  • UC Davis Health Medical Center, Sacramento
  • agus 1 a bharrachd
A’ fastadhÌre 3
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 29 Iuch 2026 · NCT06274801

A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)

  • UC Irvine Medical Center, Orange
  • Stanford Medical Center, Stanford
A’ fastadhÌre 1/2Fàilte do shaor-thoilich fhallain
Aoisean 18 gu 100 · Gach gnè · Air ùrachadh 21 Iuch 2026 · NCT06649110

A Study Evaluating the Safety and Tolerability of Artesunate in Patients With Pulmonary Arterial Hypertension

  • Stanford University, Stanford
A’ fastadhÌre 1
Aoisean 18 gu 60 · Gach gnè · Air ùrachadh 23 Gibl 2026 · NCT06872112

Study to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008)

  • The Regents of the University of California - Los Angeles (UCLA Pediatrics) ( Site 1606), Los Angeles
  • Stanford University School of Medicine ( Site 1603), Palo Alto
  • UCSF Benioff Children's Hospital San Francisco ( Site 1611), San Francisco
A’ fastadhÌre 2
Aoisean 1 gu 17 · Gach gnè · Air ùrachadh 20 Gibl 2026 · NCT05587712

Pulmonary Hypertension Association Registry

  • UC Davis Health, Sacramento
  • UCSF Medical Center, San Francisco
  • UCSF Benioff Children's Hospital, San Francisco
  • agus 2 a bharrachd
A’ fastadhSgrùdadh amharc
Aoisean 0 agus nas sine · Gach gnè · Air ùrachadh 14 Samh 2025 · NCT04071327

Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System

  • University of California-Los Angeles, Los Angeles
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 29 Sult 2025 · NCT04555161

Pediatric Pulmonary Hypertension Network (PPHNet) Informatics Registry

  • Stanford University Medical Center, Palo Alto
  • University California San Francisco, San Francisco
A’ fastadhSgrùdadh amharc
1 Day – 21 Years · Gach gnè · Air ùrachadh 13 Màrt 2025 · NCT02249923

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.